Accelerated radiotherapy with concomitant ACNU/Ara-C for the treatment of malignant glioma

Journal of Neuro-Oncology

Volumn 48, Issue 1, 2000, Pages 63-73

  Anders, K ^a   Grabenbauer, G G ^a   Schuchardt, U ^a   Fahlbusch, R ^a   Fietkau, R ^a   Sauer, R ^a   Krauseneck, P ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b University Hospitals of Erlangen Nüurnberg ^*  (Germany)

Author keywords

Accelerated radiation therapy; ACNU; Ara C; Chemotherapy; High grade glioma

Indexed keywords

ANTIBIOTIC AGENT; ANTIEMETIC AGENT; CYTARABINE; NIMUSTINE;

ADULT; AGED; ALLERGIC REACTION; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG ACTIVITY; ESOPHAGITIS; FEVER; GLIOBLASTOMA; HEMATOLOGIC DISEASE; HUMAN; LUNG EMBOLISM; NAUSEA; PNEUMONIA; RADIATION DOSE FRACTIONATION; STOMATITIS; THROMBOCYTE TRANSFUSION; VAGINITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CYTARABINE; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NIMUSTINE; RADIOTHERAPY; SURVIVAL RATE;

EID: 0033830260     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006498525605     Document Type: Article

References (43)

1. Long-term survival in treated anaplastic astrocytomas
2. Combination chemotherapy (COMP protocol) and radiotherapy of anaplastic supratentorial gliomas
3. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas
4. Randomized comparison of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery
5. Radiation therapy of malignant gliomas
6. ACNU - ein Zytostatikum der Nitrosoharnstoffreihe
7. Pharmacokinetics of a new water-soluble nitrosourea derivative (ACNU) in human gliomas
8. Effects of ACNU and radiotherapy on malignant glioma
9. Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas
10. Adjuvant intraarterial chemotherapy with nimustine in the management of World Health Organization Grade IV gliomas of the brain
11. Clinical pharmacology of 1-β-D-arabino furanosyl cytosine
12. Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid
13. Cytosine arabinoside plus cisplatin and other drugs as chemotherapy for gliomas
14. ACNU und Ara-C in der Rezidivtherapie maligner Gliome - Randomisierte Phase-II-Studie
15. Nonparametric estimation from incomplete observations
16. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas
17. Radiotherapy of glioblastoma multiforme
18. Modifying radical radiotherapy in high grade gliomas: Shortening the treatment time through acceleration
19. Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: Accelerated radiotherapy in high-grade glioma
20. Somnolence syndrome in adults following cranial irradiation for primary brain tumours
21. Chemotherapy for malignant gliomas
22. Combined modality approach to treatment of malignant gliomas - Re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: A joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group
23. Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas. EORTC Brain Tumor Group
24. Chemotherapy of malignant gliomas
25. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors
26. Pulmonale toxizitat der BCNU-therapie maligner gliome
27. Preliminary experimental results with the nitrosourea derivative ACNU in the treatment of malignant gliomas
28. Treatment of high grade glioma xenografts with nitrosoureas in nude mice
29. Long-term follow-up results of 175 patients with malignant glioma: Importance of radical tumor resection and postoperative adjuvant chemotherapy with interferon, ACNU and radiation
30. A comparison of intraarterial carboplatin and ACNU for the treatment of gliomas
31. Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD Ara-C)
32. Model for the chemotherapy of acute leukemia with 1-β-D-arabinofuranosylcytosine
33. Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma
34. Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme
35. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme
36. Steroid-induced CT-changes in patients with recurrent malignant glioma
37. Corticosteroid-induced magnetic resonance imaging changes in patients with recurrent malignant glioma
38. Chemotherapy response criteria in malignant glioma
39. Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy
40. Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: A report of Radiation Therapy Oncology Group 83-02
41. Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma
42. Results of three consecutive combined treatments for malignant gliomas, ten-year experience at a single institution
43. A randomized trial of accelerated hyperfractionated radiation therapy and bischlorethyl nitrosourea for malignant glioma